Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$8,157,770
+$1,039,922 QoQ
Shares Held
32,121
+10.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#1,231
of 4,676 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCDONALD PARTNERS LLC holds $28,881,483 across 13 Drug Manufacturers - General names. JNJ ranks #1 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
32,121 | $8,157,770 | |
| 2 | AMGN |
Amgen Inc
|
15,929 | $5,768,209 | |
| 3 | ABBV |
AbbVie Inc.
|
20,808 | $5,236,125 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
23,016 | $2,907,841 | |
| 5 | PFE |
Pfizer Inc
|
101,152 | $2,435,740 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,987 | $1,797,329 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
28,302 | $1,630,761 | |
| 8 | LLY |
ELI LILLY & Co
|
678 | $813,213 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,157,770 | 32,121 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $7,117,848 | 29,119 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,410,329 | 16,479 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,645,357 | 19,660 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,172,213 | 27,314 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,553,303 | 27,456 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,964,468 | 27,413 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $4,240,624 | 26,167 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,870,462 | 26,481 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $4,096,488 | 25,896 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $4,055,020 | 25,871 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,927,859 | 25,219 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $4,753,734 | 28,720 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $4,222,975 | 27,245 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,854,342 | 27,480 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $4,385,889 | 26,848 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $5,737,655 | 32,323 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $5,062,574 | 28,565 | Shares | Sole | 2022-04-29 | |
| 2021-09-30 | $4,285,079 | 26,533 | Shares | Sole | 2021-11-24 | |
| 2021-06-30 | $4,313,387 | 26,183 | Shares | Sole | 2021-11-24 | |
| 2021-03-31 | $4,224,288 | 25,703 | Shares | Sole | 2021-11-24 | |
| 2020-12-31 | $3,872,807 | 24,608 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||